The Video Signal

Topic

Computational Biology

All digests tagged Computational Biology

A Worm With 302 Neurons Inspired Their Architecture — Ramin Hasani, Liquid AI thumbnail

· 1:09:52

A Worm With 302 Neurons Inspired Their Architecture — Ramin Hasani, Liquid AI

Liquid AI presents a comprehensive view of the next generation of AI architectures, moving beyond pure Transformer models. Their approach is inspired by biological systems, specifically the continuous-time dynamics of worms, leading to the development of Liquid Neural Networks (LNNs). The company emphasizes a 'meta AI' system that systematically searches for hybrid, hardware-aware architectures (e.g., combining convolutions, attention, and LNN elements) to achieve high quality while minimizing memory and latency. A major focus is enabling reliable, high-intelligence deployment at the edge (on-device, in cars, and on laptops), addressing critical needs for privacy, cost efficiency, and air-gapped capabilities.

Key takeaways

  1. Biological Inspiration and Continuous Dynamics 1:55

    Liquid AI's foundational research is inspired by the worm's nervous system, which uses simple first-order differential equations. This leads to Liquid Neural Networks (LNNs), which are continuous-time, differentiable systems, allowing for backpropagation and learning while maintaining biological fidelity. (01:15-02:00)

  2. Architectural Search for Efficiency 4:20

    Instead of committing to a single architecture, Liquid uses a meta AI system to search for optimal hybrid architectures. This search optimizes four criteria: no sacrifice on quality, minimizing memory consumption, minimizing latency, and maximizing computation speed, making the models hardware-aware. (04:20-05:30)

  3. Edge and On-Device Intelligence 8:20

    The company is focused on bringing high-quality intelligence outside of data centers (e.g., cars, laptops, mobile devices). This is driven by cost considerations and the need for enhanced privacy, enabling local, air-gapped capabilities. (08:20-09:30)

  4. The Future of AI: Multimodality and Adaptability 12:40

    Future research focuses on massively multimodal systems (audio, vision, text, DNA) and achieving 'adaptive intelligence'—systems that can combine forward and backward passes simultaneously, moving beyond static training paradigms. (12:40-13:30)

Watch on YouTube Full article

🔬Biology Is Turning Into Software — Matt McPartland & Neil Patel, Chai Discovery thumbnail

· 1:35:20

🔬Biology Is Turning Into Software — Matt McPartland & Neil Patel, Chai Discovery

The intersection of biology and software is transforming drug discovery from a slow 'waterfall' process into an agile, iterative loop. Chai Discovery leverages advanced AI models (Chai-2, Chai-3) that function as sophisticated design suites—more akin to SolidWorks or Figma than ChatGPT. These platforms enable the co-design of protein sequences and structures, allowing researchers to move beyond simple structure prediction toward generating novel therapeutic candidates with high precision for complex modalities like ADCs and bispecifics.

Key takeaways

  1. Platform Design vs. Chatbot Interface

    The product is designed as a visual, highly functional design suite (like Autodesk or SolidWorks), allowing users to 'paint' epitopes and generate binders, rather than operating through conversational prompts.

  2. AI Model Progression for Drug Design 42:29

    Chai models progressed from Chai-1 (structure prediction) to Chai-2 (all-atom diffusion model capable of design), crossing the threshold into generating candidate molecules that bind to a target structure, which is critical for drug development.

  3. Shifting Drug Discovery Paradigms 20:39

    The process is moving from a costly, multi-year 'waterfall' model (target discovery $ ightarrow$ hit discovery $ ightarrow$ optimization) toward an agile, iterative loop where AI models provide rapid, promising candidates for continuous refinement.

Watch on YouTube Full article

How AI Helps Solve Medical Mysteries at Boston Children’s Hospital | OpenAI Forum thumbnail

· 39:32

How AI Helps Solve Medical Mysteries at Boston Children’s Hospital | OpenAI Forum

Researchers at Boston Children’s Hospital's Manton Center for Orphan Disease Research demonstrated how AI-driven workflows can significantly accelerate the diagnosis of rare genetic diseases. Using models like OpenAI o3 Deep Research, the team analyzed complex genomic data (e.g., whole genome sequencing) and clinical phenotypes to surface novel leads. In one study involving 376 cases, this process led to 18 diagnoses of rare diseases, highlighting AI's potential to transform the 'diagnostic odyssey' by efficiently narrowing massive datasets for expert review.

Key takeaways

  1. AI accelerates diagnosis from vast data sets 20:05

    The workflow uses LLMs to intersect genetic variants (e.g., denovo mutations, deletions/duplications) with curated clinical metadata (ontological codes for phenotypes). This dramatically reduces the search space of thousands of potential variants down to a small, focused list for human diagnosticians.

  2. AI successfully identified rare diagnoses 25:20

    In a study across 376 cases, the AI-driven workflow surfaced evidence that led to 18 confirmed diagnoses of rare diseases. The model can also suggest gene-phenotype associations based on literature even when those links were previously unknown.

  3. The diagnostic process is iterative and requires human oversight 21:45

    While the AI accelerates analysis, it does not replace the diagnostician. The model's output must be reviewed by experts who validate the evidence-driven list of hypotheses to ensure accuracy and guide follow-on testing.

Watch on YouTube Full article